Crinetics Pharmaceuticals Doses First Patient in P-II/III (BALANCE-CAH) Trial of Atumelnant for Pediatric Congenital Adrenal Hyperplasia
Shots: Ref: Globenewswire | Image: Crinetics | Press Release Related News: Crinetics Pharmaceuticals Reports the US…
Read article →
BPGbio’s BPM31510 Receives the US FDA Orphan Drug Designation to Treat Primary CoQ10 Deficiency
Shots: Ref: BPGbio | Image: BPGbio | Press Release Related News: iRegene Therapeutics’ NouvNeu001 Receives the US FDA…
Read article →
Mabwell Doses First US Patient in P-I/II Trial of 7MW4911 for Gastrointestinal (GI) Cancers
Shots: Ref: PRnewswire | Image: Mabwell | Press Release Related News: Mabwell’s Adalimumab Injection (Biosimilar,…
Read article →
Rechargeable E-Cigarettes vs Disposables: Making the Right Choice
Introduction The vaping market presents newcomers with a fundamental decision: purchase disposable devices offering…
Read article →
Guardant Health Secures the US FDA Approval for Guardant360 CDx as a Companion Diagnostic for Pfizer’s Braftovi
Shots: Ref: Businesswire | Image: Guardant Health | Press Release Related News: CereVasc Completes Patient Enrolment…
Read article →
Corcept Therapeutics Reports P-III (ROSELLA) Trial Data on Relacorilant for Platinum-Resistant Ovarian Cancer (PROC)
Shots: Ref: Businesswire | Image: Corcept | Press Release Related News: Corcept Therapeutics Reports the EMA’s MAA…
Read article →
Janux Therapeutics and BMS Forge ~$850M Deal to Develop Therapies in Oncology
Shots: Ref: Businesswire | Image: BMS & Janux | Press Release Related News: insitro and Bristol Myers Squibb Collaborate…
Read article →
2025 EMA Drug Approvals Outlook: A Year of Intentional, Biology Led Medicine Across Europe
Shots: A European Perspective on Precision 2025 is shaping up to be a defining year for EMA approvals, not by sheer…
Read article →